Personalis Inc (PSNL)
Healthcare
Diagnostics & Research
13.50 $
+2.4%
vs. previous close
Closing price · As of: 4. Aug 2026
All figures as a percentage of revenue in the same period.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -62.4% | -91.4% | -68.2% | -104.5% | -47.6% | -24.1% | -46.4% | -87.2% | -75.2% | -150.4% | -128.3% | -145.3% | -123.2% | |
| 17.1% | 15.1% | 14.8% | 14.5% | 12.4% | 10.7% | 15.1% | 12.6% | 14.7% | 17.0% | 14.2% | 15.3% | 15.2% | |
| 20.9% | 19.1% | 17.2% | 13.8% | 11.7% | 10.4% | 15.9% | 10.8% | 16.5% | 14.4% | 13.2% | 16.5% | 15.1% | |
| 21.4% | 54.4% | – | – | – | – | – | – | – | – | – | – | – | |
| 45.6% | -1.5% | 6.1% | -41.1% | -0.2% | 6.3% | 23.0% | -28.9% | 13.7% | -29.0% | -13.9% | 23.1% | -1.0% | |
| 16.4% | 4.8% | 17.9% | 0.5% | 0.0% | 1.0% | 7.4% | 12.2% | 1.7% | 11.2% | 0.4% | 20.6% | 8.0% | |
| 117.1% | -47.2% | -59.2% | 32.3% | 57.5% | -109.6% | -155.9% | -109.4% | -25.4% | 129.2% | -82.9% | -297.4% | -71.4% | |
| 16.7% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -11.1% | -2.4% | – | – | – | -1.2% | -1.8% | 11.1% | -5.8% | -2.8% | -1.6% | -22.0% | -7.9% | |
| 5.5% | 1.6% | 49.9% | 5.8% | 6.7% | 242.8% | 295.2% | 97.5% | -1.9% | -2.2% | 639.3% | 115.2% | 198.5% | |
| 60.0% | -137.0% | -77.3% | -66.6% | 16.7% | 109.1% | 92.9% | -99.1% | -102.5% | -23.5% | 428.2% | -327.4% | 4.0% | |
| -78.8% | -96.2% | -86.1% | -105.1% | -47.6% | -25.1% | -53.8% | -99.4% | -76.9% | -161.6% | -128.7% | -165.9% | -131.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.